Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Onconetix, Inc.
Onconetix, Inc. provided an additional $500,000 advance to Realbotix, LLC on October 22, 2026. This brings the total aggregate principal amount outstanding under the previously disclosed promissory note to $3.0 million.…more
Onconetix, Inc.
Onconetix, Inc. has provided an additional $500,000 advance to Realbotix, LLC. Following this transaction, the aggregate principal amount outstanding under the existing Grid Promissory Note has reached $3.0 million.…more
Onconetix, Inc.
Onconetix has provided an additional $500,000 advance to Realbotix, bringing the total outstanding principal under their strategic bridge financing facility to $3,000,000. This facility will be automatically cancelled and discharged in full upon the closing of the pending acquisition.…more
33 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Onconetix Provides Additional $500K Bridge Financing to Realbotix
Onconetix has provided an additional $500,000 in bridge financing to Realbotix, bringing the total facility to $3 million. This funding supports the pending acquisition and will be automatically discharged upon the deal's closing.…more
●●●●●●●● ●●●●● ●●●●●●
Onconetix has provided a bridge financing facility of up to $5 million to support Realbotix as they move toward their pending acquisition. The facility will be automatically discharged upon the successful closing of the acquisition deal.…more
●●●●●●●● ●●●●● ●●●●●●
Onconetix is providing up to $5 million in bridge financing to support the operations of its acquisition target, Realbotix. The facility is designed to facilitate the pending merger and will be discharged upon the successful closing of the transaction.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.